AI and Decentralized Trials: A New Era in Drug Development
Healthcare IT Today
MAY 7, 2025
The following is a guest article by Matt Noble, Head of Patient Experience at Medidata The decentralized clinical trial (DCT) model has been around for almost fifteen years , with Pfizer pioneering the first fully decentralized study in 2011, and adoption accelerating significantly following the onset of the COVID-19 pandemic in 2020. The clinical research landscape is currently undergoing a profound transformation, driven by the increasing employment of decentralized clinical trials.
Let's personalize your content